These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18458051)

  • 1. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
    Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
    Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein predicts cardiovascular events and myocardial damage after vascular surgery.
    Scrutinio D; Passantino A; Di Serio F; Angiletta D; Santoro D; Regina G
    J Vasc Surg; 2011 Aug; 54(2):474-9. PubMed ID: 21458205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C-protein C inhibitor complex in peripheral arterial disease.
    Blomstrand D; Kölbel T; Lindblad B; Gottsäter A
    Ann Vasc Surg; 2010 Jul; 24(5):588-95. PubMed ID: 20409682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study.
    Sprengers RW; Janssen KJ; Moll FL; Verhaar MC; van der Graaf Y;
    J Vasc Surg; 2009 Dec; 50(6):1369-76. PubMed ID: 19837547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.
    LeLeiko RM; Vaccari CS; Sola S; Merchant N; Nagamia SH; Thoenes M; Khan BV
    Am J Cardiol; 2009 Sep; 104(5):638-43. PubMed ID: 19699337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).
    Beckman JA; Preis O; Ridker PM; Gerhard-Herman M
    Am J Cardiol; 2005 Nov; 96(10):1374-8. PubMed ID: 16275181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is high-sensitivity C-reactive protein associated with subclinical peripheral atherosclerosis?
    Paraskevas KI; Bessias N; Papas TT; Andrikopoulos V; Mikhailidis DP
    Angiology; 2009; 60(1):8-11. PubMed ID: 19190029
    [No Abstract]   [Full Text] [Related]  

  • 11. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment in the patient with established peripheral arterial disease.
    Haugen S; Casserly IP; Regensteiner JG; Hiatt WR
    Vasc Med; 2007 Nov; 12(4):343-50. PubMed ID: 18048472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein.
    Artieda M; Cenarro A; Gañán A; Lukic A; Moreno E; Puzo J; Pocoví M; Civeira F
    Cardiology; 2007; 108(4):297-306. PubMed ID: 17290100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease.
    Unlü Y; Karapolat S; Karaca Y; Kiziltunç A
    Thromb Res; 2006; 117(4):357-64. PubMed ID: 15890391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease.
    Brevetti G; Schiano V; Laurenzano E; Giugliano G; Petretta M; Scopacasa F; Chiariello M
    Eur Heart J; 2008 Jan; 29(2):224-30. PubMed ID: 18156137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
    Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of neutrophils and future cardiovascular events in patients with peripheral artery disease.
    Haumer M; Amighi J; Exner M; Mlekusch W; Sabeti S; Schlager O; Schwarzinger I; Wagner O; Minar E; Schillinger M
    J Vasc Surg; 2005 Apr; 41(4):610-7. PubMed ID: 15874924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity C-reactive protein: clinical importance.
    Bassuk SS; Rifai N; Ridker PM
    Curr Probl Cardiol; 2004 Aug; 29(8):439-93. PubMed ID: 15258556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    ; Leizorovicz A; Becker F
    Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.